Helen Thackray
Chief Medical Officer
Other
Other
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Biocryst Pharmaceuticals Inc (BCRX) | Former Chief R&D Officer | $425,999 | $4,339,624 |
| 2024 | Biocryst Pharmaceuticals Inc (BCRX) | Chief R&D Officer | $599,423 | $3,568,850 |
| 2023 | Biocryst Pharmaceuticals Inc (BCRX) | Chief R&D Officer | $576,368 | $2,393,933 |
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | Chief R&D Officer | $554,200 | $3,497,932 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | Chief R&D Officer | $425,125 | $6,881,396 |
Earnings-call appearances
-
Biocryst Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2025 Earnings Call2025-05-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-02-24
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2023 Earnings Call2023-08-03
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2023 Earnings Call2023-05-03
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2022 Earnings Call2023-01-09
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-01
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-01-10
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-03
Biocryst Pharmaceuticals Inc (BCRX)